Infection and Immunity · 2014 · 74 citations · 29 references
Life SciencesImmunologyInfectious DiseasesHost-pathogen InteractionsInnate ImmunityProtein-protein InteractionsComplement RegulationComplement SystemHuman Leukocyte Antigen SystemInnate Immune RecognitionPathogen RecognitionProtein Interaction DomainsBinding AssaysCompetitive AssaysCompetitive Binding AssaysComplement In Host DefenseComplement RegulatorsInnate Immunity PathwaysMembrane Attack ComplexTerminal Pathway Inhibition
Upon infection, pathogenic Leptospira species bind several complement regulators in order to overcome host innate immunity. We previously characterized a 20-kDa leptospiral surface protein which interacts with C4b binding protein (C4BP): leptospiral complement regulator-acquiring protein A (LcpA). Here we show that LcpA also interacts with human factor H (FH), which remains functionally active once bound to the protein. Antibodies directed against short consensus repeat 20 (SCR20) inhibited binding of FH to LcpA by approximately 90%, thus confirming that this particular domain is involved in the interaction. We have also shown for the first time that leptospires bind human vitronectin and that the interaction is mediated by LcpA. Coincubation with heparin blocked LcpA-vitronectin interaction in a dose-dependent manner, strongly suggesting that binding may occur through the heparin binding domains of vitronectin. LcpA also bound to the terminal pathway component C9 and inhibited Zn(2+)-induced polymerization and membrane attack complex (MAC) formation. Competitive binding assays indicated that LcpA interacts with C4BP, FH, and vitronectin through distinct sites. Taken together, our findings indicate that LcpA may play a role in leptospiral immune evasion.
29
Michael K. Pangburn, Robert D. Schreiber, Hans J. Müller‐Eberhard · The Journal of Experimental Medicine · 1977 · 684 citations · Full text
Henry A. Choy, Melissa M. Kelley, Tammy L. Chen et al. · Infection and Immunity · 2007 · 286 citations · Full text